RESUMO
OBJECTIVE: The objective of the study was to test the hypothesis that the total number of cells in the cortical part of the cerebral wall is the same in intrauterine growth-restricted (IUGR) fetuses, compared with normally grown fetuses. STUDY DESIGN: The total cell number in the cerebral wall was estimated in 9 severely affected IUGR fetuses and 15 controls using the optical fractionator. Cell numbers were estimated within 4 developmental zones. The gestational ages were 19-41 weeks. RESULTS: The total cell number in the future cortex was significantly reduced in the IUGR fetuses, compared with controls. The daily increase in brain cells in the future cortex was only half of that of the controls. In the 3 other developmental zones, no significant differences in cell numbers could be demonstrated. CONCLUSIONS: IUGR in humans is associated with a severe reduction in cortical growth and a significant decrease in cell number in the future cortex.
Assuntos
Encefalopatias/embriologia , Córtex Cerebral/citologia , Córtex Cerebral/embriologia , Retardo do Crescimento Fetal/fisiopatologia , Peso ao Nascer , Estudos de Casos e Controles , Contagem de Células , Feminino , Idade Gestacional , Humanos , Recém-Nascido , Masculino , GravidezAssuntos
Complicações na Gravidez/imunologia , Isoimunização Rh/prevenção & controle , Imunoglobulina rho(D)/administração & dosagem , Aborto Induzido/efeitos adversos , Aborto Espontâneo/complicações , Aborto Espontâneo/imunologia , Medicina Baseada em Evidências , Feminino , Humanos , Guias de Prática Clínica como Assunto , Gravidez , Primeiro Trimestre da Gravidez/imunologia , Segundo Trimestre da Gravidez/imunologia , Gravidez Ectópica/complicações , Gravidez Ectópica/imunologia , Isoimunização Rh/etiologia , Fatores de RiscoAssuntos
Complicações na Gravidez/imunologia , Isoimunização Rh/prevenção & controle , Imunoglobulina rho(D)/administração & dosagem , Feminino , Transfusão Feto-Materna/complicações , Transfusão Feto-Materna/imunologia , Humanos , Período Pós-Parto/imunologia , Guias de Prática Clínica como Assunto , Gravidez , Segundo Trimestre da Gravidez/imunologia , Terceiro Trimestre da Gravidez/imunologia , Transtornos Puerperais/imunologia , Isoimunização Rh/etiologia , Fatores de RiscoRESUMO
BACKGROUND: Adaptive alterations in maternal physiology cause changes in thyroid hormone levels throughout pregnancy, and precise biochemical evaluation is thus highly dependent on gestation-specific reference intervals and expected intra-individual variation. OBJECTIVE: The aim of the study was the assessment of the intra-individual variation as well as the longitudinal course of thyroid hormones during normal pregnancy and factors that influence the normal reference range for thyroid function. For this purpose, a longitudinal statistical model was applied. DESIGN: In a cohort of 132 pregnant women, serial blood samples were obtained and ultrasound scans were performed throughout pregnancy. METHODS: Serum levels of TSH, free and total thyroxine (T(4)), free and total triiodothyronine (T(3)) as well as autoantibodies against thyroid peroxidase and thyroglobulin were measured in 979 serum samples. RESULTS: Intra-individual variations of thyroid hormone concentrations were smaller than inter-individual variations (individuality index range: 0.38-0.71). Maternal height was positively associated with free T(4) (FT(4)) (b=0.003; P=0.031) and pre-pregnancy body mass index with T(3) and free T(3) (b=0.017; <0.001 and b=0.007; P<0.001). Smoking was positively associated with T(4) and FT(4), but it was modulated by gestational age. Gestation-specific reference intervals for thyroid function variables from autoantibody-negative participants are presented. CONCLUSIONS: In accordance with the data from nonpregnant adults, intra-individual variations of thyroid hormones were smaller than inter-individual variations also during pregnancy. In the evaluation of thyroid function in pregnancy, the individual longitudinal course of thyroid hormones rather than absolute values should be considered. We present a longitudinal model for the prediction of maternal thyroid function tests in pregnant women.
Assuntos
Glândula Tireoide/fisiologia , Adulto , Estatura , Feminino , Humanos , Estudos Longitudinais , Pessoa de Meia-Idade , Gravidez , Valores de Referência , Tiroxina/sangue , Tri-Iodotironina/sangueRESUMO
The total number of cells--including both neurons and glial cells - was estimated in the neocortical part of the human fetal telencephalon in 22 normal brains within four major developmental zones: the cortical plate/marginal zone, the subplate, the intermediate zone and the ventricular/subventricular zone. The fetal ages ranged from 13 to 41 weeks of gestation. The cellular growth in the human fetal forebrain appears to be two-phased: one rapid, exponential phase from 13 to 20 weeks of gestation and a second and slower phase, which increases linearly, from approximately 22 weeks of gestation to term. From 13 to 20 weeks of gestation the total number of cells increases by a factor of 4.3 from 3 x 10(9) cells to 13 x 10(9) cells at 20 weeks of gestation. From mid-gestation to term, the total cell number increases by a factor of 2.9 to 38 x 10(9) cells in the newborn infant. Studying cellular growth in the normal human fetal brain is important since it may serve as a useful parameter for the assessment of cortical growth in non-invasive and histological studies, and thus improve the analysis of fetal brain disturbances.